More than seven million additional Americans could get coverage for popular drugs such as Zepbound and Wegovy under the ...

President-elect Donald Trump's agenda carries risks and rewards for various investment sectors, market experts said.

Nobody can predict the future, but it's not hard to imagine increasing pharmaceutical sales. In 2022, prescription drug ...

Pfizer's high initial dividend yield, solid ratings, and promising pipeline make it a potentially undervalued investment. See ...

The world’s largest pharmaceutical company by 2023 revenue, Pfizer Inc. (PFE) is down more than 13% year-to-date, while the ...

Pfizer (PFE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Manitobans, like all Canadians, have no choice but to consider what will be impacted by Donald Trump's proposed tariffs. In ...

Pneumococcal vaccines address infections caused by pneumococcal bacteria, including pneumonia, meningitis, and blood ...

Health disparities in marginalized communities are rooted in systemic factors such as discrimination and unequal access to ...

The power of owning dividend-paying stocks is often underappreciated. Consider, for example, that a study by Hartford Funds ...

Learn about this vaccine that protects against a common seasonal virus that can sometimes cause severe disease, with info on ...

It's been nearly five years since the pandemic started, but COVID-19 doesn't take a break over the holidays. From shopping to ...